Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation

Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance

(2010) P. J. F. Martins et al.   DIABETES

Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender

(2010) Ricardo Lage et al.   FASEB JOURNAL

Influence of Ghrelin and Growth Hormone Deficiency on AMP-Activated Protein Kinase and Hypothalamic Lipid Metabolism

(2010) S. Sangiao-Alvarellos et al.   JOURNAL OF NEUROENDOCRINOLOGY

Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance

(2010) Miguel López et al.   NATURE MEDICINE

Preclinical models of antipsychotic drug-induced metabolic side effects

(2010) Heidi N. Boyda et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Additive effects of olanzapine and melanin-concentrating hormone agonism on energy balance

(2009) Benjamin Guesdon et al.   BEHAVIOURAL BRAIN RESEARCH

30 Days of Continuous Olanzapine Infusion Determines Energy Imbalance, Glucose Intolerance, Insulin Resistance, and Dyslipidemia in Mice

(2009) Roberto Coccurello et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

The AMPK-Malonyl-CoA-CPT1 Axis in the Control of Hypothalamic Neuronal Function—Reply

(2008) Miguel López et al.   Cell Metabolism

Hypothalamic Fatty Acid Metabolism Mediates the Orexigenic Action of Ghrelin

(2008) Miguel López et al.   Cell Metabolism

Central Resistin Regulates Hypothalamic and Peripheral Lipid Metabolism in a Nutritional-Dependent Fashion

(2008) María J. Vázquez et al.   ENDOCRINOLOGY

Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA

(2008) M D Lane et al.   INTERNATIONAL JOURNAL OF OBESITY

Olanzapine (LY170053, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] Benzodiazepine), but Not the Novel Atypical Antipsychotic ST2472 (9-Piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), Chronic Administration Induces Weight Gain, Hyperphagia, and Metabolic Dysregulation in Mice

(2008) R. Coccurello et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals

(2008) Zane B. Andrews et al.   NATURE

Adiposity and Eating Behaviors in Patients Under Second Generation Antipsychotics

(2008) Mélissa Blouin et al.   Obesity

Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver

(2008) Johan Fernø et al.   PSYCHOPHARMACOLOGY

Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine

(2008) Nima Davoodi et al.   PSYCHOPHARMACOLOGY

Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin

(2008) Hua Jin et al.   SCHIZOPHRENIA RESEARCH

AMPK: a metabolic gauge regulating whole-body energy homeostasis

(2008) Ricardo Lage et al.   TRENDS IN MOLECULAR MEDICINE

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: Implications for animal models of antipsychotic-induced weight gain

(2007) G.D. Cooper et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY